Get started
Biogen Inc. 4.05% 15-SEP-2025Biogen Inc. 4.05% 15-SEP-2025Biogen Inc. 4.05% 15-SEP-2025

Biogen Inc. 4.05% 15-SEP-2025

No trades
See on Supercharts
Overview
Chart Analysis News

BIIB4288324 chart



Key terms


Outstanding amount
‪1.75 B‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
4.05% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
4.31%
Maturity date
Sep 15, 2025
Term to maturity
2 months

About Biogen Inc. 4.05% 15-SEP-2025


Issuer
Biogen, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
biogen.com
Issue date
Sep 15, 2015
FIGI
BBG009ZYVZZ7
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

See how Biogen, Inc. is moving with its highest-yielding bonds.

BIIB4288324 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

BIIB4288324 news